✦ LIBER ✦

Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer

✍ Scribed by Lorenzo Livi; Icro Meattini; Calogero Saieva; Ciro Franzese; Vanessa Di Cataldo; Daniela Greto; Davide Franceschini; Vieri Scotti; Pierluigi Bonomo; Jacopo Nori; Luis Sanchez; Vania Vezzosi; Simonetta Bianchi; Luigi Cataliotti; Giampaolo Biti

Book ID: 112066975
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 232 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26647

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic evaluation of the 70-gene progn

Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan

✍ Masahide Kondo, Shu-Ling Hoshi, Hiroshi Ishiguro, Masakazu Toi 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 281 KB

Adjuvant trastuzumab reduces locoregiona

Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer

✍ Ana P. Kiess; Heather L. McArthur; Kathleen Mahoney; Sujata Patil; Patrick G. Mo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 876 KB

Lack of prognostic value of epidermal gr

Lack of prognostic value of epidermal growth factor receptor in a series of 229 T1/T2, N0/N1 breast cancers, with well defined prognostic parameters

✍ M. Bolla; M. Chedin; M. Colonna; J. Marron-Charrière; B. Rostaing-Puissant; D. P 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 451 KB

Prognostic value of epidermal growth fac

Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer

✍ Shinichi Tsutsui; Shinji Ohno; Shigeru Murakami; Yoichi Hachitanda; Shinya Oda 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 98 KB

A phase 1 study of weekly dosing of tras

A phase 1 study of weekly dosing of trastuzumab emtansine (T-DM1) in patients with advanced human epidermal growth factor 2–positive breast cancer

✍ Muralidhar Beeram; Ian E. Krop; Howard A. Burris; Sandhya R. Girish; Wei Yu; Mic 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

Topoisomerase II alpha expression and th

Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer

✍ Hideaki Tokiniwa, Jun Horiguchi, Daisuke Takata, Mami Kikuchi, Nana Rokutanda, R 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 358 KB